Publication Spotlight

Professor Karlheinz Peter, Head of the Baker Department of Cardiometabolic Health, and Dr James McFadyen, Haematologist and Research Fellow at the Baker Heart and Diabetes Institute, have co-authored an article addressing the risk of blood clots associated with the AstraZeneca vaccine. The article, “How rare are blood clots after the AstraZeneca vaccine? What should you look out for? And how are they treated?” was published in The Conversation and featured on ABC news this morning.

Professor Karlheinz Peter, Head of the Baker Department of Cardiometabolic Health, and Dr James McFadyen, Haematologist and Research Fellow at the Baker Heart and Diabetes Institute, have co-authored an article addressing the risk of blood clots associated with the AstraZeneca vaccine. The article, “How rare are blood clots after the AstraZeneca vaccine? What should you look out for? And how are they treated?” was published in The Conversation and featured on ABC news this morning.

The article has been published at a time where COVID-19 community transmission is on the rise and those aged over 50 are weighing up the benefits of being vaccinated against the virus with the very rare risk of blood clotting induced by the AstraZeneca vaccine. The article addresses the following questions:

• How common and deadly is it?
• What is the current clotting rate from the AstraZaneca vaccine in Australia?
• What exactly is thrombosis with thrombocytopenia syndrome?
• What side effects are normal, and what might indicate a clot?

The article can be viewed at this link.